U.S. Health Secretary Robert F. Kennedy Jr. is reportedly advocating for increased access to a range of unapproved peptides, including BPC-157, TB-500, KPV, MOTS-c, and Semax. Under this proposal, compounding pharmacies would be permitted to create medications using these substances. The Food and Drug Administration (FDA) has been contacted for comment.
An FDA advisory panel had previously voted in July to relax restrictions on six specific peptides. However, FDA staff members ultimately advised against this course of action. Kennedy has expressed his strong support for these drugs and has previously indicated an intention to loosen restrictions on them, following a clampdown by the Biden administration on the burgeoning peptide industry.
Peptides are naturally occurring short chains of amino acids, or small proteins, that function as messengers within the body, directing cellular activity. They play critical roles in maintaining skin health, regulating the immune system, and managing hormone levels. For over a century, peptides have been utilized in the treatment of various medical conditions. Insulin, one of the earliest discovered peptide hormones, aids individuals with Type 1 diabetes and some with Type 2 diabetes in managing their blood sugar.
The wellness market has seen an explosion of unregulated peptides, particularly since the rise in popularity of GLP-1s, commonly known as weight-loss drugs. Online influencers have been marketing peptides, sometimes in combinations referred to as "stacks," for uses that lack scientific evidence. Claims suggest these substances can serve as quick solutions for anti-aging, healing, or skin improvement.
These peptides have gained traction among teenagers on platforms like TikTok, especially among boys, fueled by unverified claims of their ability to build muscle. This trend is part of broader online movements such as "biohacking" and "looksmaxxing." However, health experts have voiced concerns regarding the use of these drugs, citing a lack of comprehensive human clinical trials and uncertainties surrounding their long-term effects.